Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

Trends in Neurosciences

Volumn 20, Issue 1, 1997, Pages 31-37

  Grace, Anthony A ^a   Bunney, Benjamin S ^b   Moore, Holly ^a   Todd, Christopher L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[2 (DIMETHYLAMINO)ETHYL]THIO] 3 PHENYLQUINOLINE; APOMORPHINE; CHLORPROMAZINE; CLOZAPINE; EMONAPRIDE; HALOPERIDOL; METOCLOPRAMIDE; MOLINDONE; NEUROLEPTIC AGENT; QUETIAPINE; REMOXIPRIDE; SERTINDOLE; SULPIRIDE; THIORIDAZINE; ZACOPRIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; BEHAVIOR; CATALEPSY; DEPOLARIZATION; DOPAMINERGIC NERVE CELL; HUMAN; LIMBIC SYSTEM; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; DOPAMINE; DOPAMINE AGONISTS; MEMBRANE POTENTIALS; MODELS, NEUROLOGICAL;

EID: 0031060092     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(96)10064-3     Document Type: Review

References (71)

1. Carlsson, A. and Lindqvist, M. (1963) Acta Pharmacol. Toxicol. 20, 140-144
2. Johnstone, E.C. et al. (1978) Lancet 1, 848-851
3. Wistedt, B. (1987) Am. J. Psychiatry 144, 1084-1085
4. Nyberg, S. et al. (1995) Int. Clin. Psychopharmacol. 10 (Suppl. 3), 81-85
5. Baldessarini, R.J., Cohen, B.M. and Teicher, M.H. (1988) Arch. Gen. Psychiatry 45, 79-91
6. Bunney, B.S. and Grace, A.A. (1978) Life Sci. 23, 1715-1728
7. Grace, A.A. and Bunney, B.S. (1986) J. Pharmacol. Exp. Ther. 238, 1092-1100
8. Grace, A.A. and Bunney, B.S. (1983) Neuroscience 10, 301-315
9. Curtis, D.R., Phillis, J.W. and Watkins, J.C. (1960) J. Physiol. 150, 656-682
10. White, F.J. and Wang, R.Y. (1983) Life Sci. 32, 983-993
11. Jiang, L.H., Tsai, M. and Wang, R.Y. (1988) Life Sci. 43, 75-81
12. Stille, G. and Hippius, H. (1971) Pharmacopsychiatry 4, 182-191
13. Chiodo, L.A. and Bunney, B.S. (1983) J. Neurosci. 3, 1607-1619
14. White, F.J. and Wang, R.Y. (1983) Science 221, 1054-1057
15. Chiodo, L.A. and Bunney, B.S. (1985) J. Neurosci. 5, 2539-2544
16. Goldstein, J.M. et al. (1993) Psychopharmacology 112, 293-298
17. Jenner, P. and Marsden, C.D. (1979) Life Sci. 25, 479-486
18. Owen, R.R., Jr and Cole, J.O. (1989) Clin. Psychopharmacol. 9, 268-276
19. Reynolds, G.P. (1992) Trends Pharmacol. Sci. 13, 116-121
20. Skarsfeldt, T. (1988) Life Sci. 42, 1037-1044
21. Skarsfeldt, T. (1992) Synapse 10, 25-33
22. Skarsfeldt, T. (1993) Eur. J. Pharmacol. 240, 269-275
23. O'Donnell, P. and Grace, A.A. (1996) in Handbook of Experimental Pharmacology: Antipsychotics (Csernansky, J.G., ed.), pp. 163-202, Springer-Verlag
24. Bunney, B.S. et al. (1973) J. Pharmacol. Exp. Ther. 185, 560-571
25. Mereu, G., Casu, M. and Gessa, G.L. (1983) Brain Res. 264, 105-110
26. Mereu, G. et al. (1994) Eur. J. Pharmacol. 264, 449-453
27. Mereu, G. et al. (1995) J. Neurosci. 15, 1144-1149
28. Matteo, R.S. et al. (1977) Anesthesiology 46, 396-399
29. Dajas, F. et al. (1983) Exp. Neurol. 79, 160-167
30. Yokoi, I. et al. (1992) J. Neural Transm. 87, 37-47
31. Hollerman, J.R. and Grace, A.A. (1989) Neurosci. Lett. 96, 82-88
32. Pucak, M.L. and Grace, A.A. (1994) J. Pharmacol. Exp. Ther. 271, 1181-1192
33. Pucak, M.L. and Grace, A.A. (1996) Brain Res. 713, 44-52
34. Grace, A.A. and Bunney, B.S. (1979) Eur. J. Pharmacol. 59, 211-218
35. Grace, A.A. and Bunney, B.S. (1985) Brain Res. 333, 271-284
36. Tong, Z-Y., Overton, P.G. and Clark, D. (1996) Synapse 22, 195-208
37. Smith, I.D. and Grace, A.A. (1992) Synapse 12, 287-303
38. Gerfen, C.R. (1984) Nature 311, 461-464
39. Gerfen, C.R., McGinty, J.F. and Young, W.S. (1991) J. Neurosci. 11, 1016-1031
40. Normand, E. et al. (1988) Brain Res. 439, 39-46
41. Tang, F., Costa, E. and Schwartz, J.P. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 3841-3844
42. Henry, D.J. et al. (1992) Brain Res. 596, 231-237
43. Hollerman, J.R. and Grace, A.A. (1992) Brain Res. 590, 291-299
44. Braszko, J.J. et al. (1981) J. Pharmacol. Exp. Ther. 216, 289-293
45. Hollerman, J.R., Abercrombie, E.D. and Grace, A.A. (1992) Neuroscience 47, 589-601
46. Keefe, K.A. et al. (1990) Brain Res. 527, 350-353
47. Pucak, M.L. and Grace, A.A. (1991) Synapse 9, 144-155
48. Skirboll, L.R. and Bunney, B.S. (1979) Life Sci. 25, 1419-1434
49. Onn, S-P. and Grace, A.A. (1995) J. Neurosci. 15, 7024-7036
50. Rompré, P-P. and Wise, R.A. (1989) Brain Res. 477, 152-156
51. Doherty, M.D. and Gratton, A. (1991) Behav. Neurosci. 105, 579-587
52. Andén, N-E., Grendhoff, J. and Svensson, T.H. (1988) Psychopharmacology 96, 558-560
53. Benveniste, H. (1991) in Measuring the Chemical Microenvironment (Gardner, E. and Nicholson, C., eds), pp. 54-64, Society for Neuroscience
54. Benveniste, H. and Hüttemeier, P.C. (1990) Prog. Neurobiol. 35, 195-215
55. Ichikawa, J. and Meltzer, H.Y. (1990) Brain Res. 507, 738-742
56. Todd, C.L. et al. (1996) Soc. Neurosci. Abstr. 22, 359
57. Ichikawa, J. and Meltzer, H.Y. (1991) J. Pharmacol. Exp. Ther. 256, 348-357
58. Hernandez, L. and Hoebel, B. (1989) Brain Res. Bull. 22, 763-769
59. Patterson, T.A. and Schenk, J.O. (1991) Neuropharmacology 30, 943-952
60. Lane, R.F. and Blaha, C.D. (1987) Brain Res. Bull. 18, 135-138
61. Feasey-Truger, K.J. et al. (1995) Neurosci. Lett. 183, 91-95
62. Grace, A.A. (1991) Neuroscience 41, 1-24
63. Nowak, J.Z. et al. (1983) J. Pharmacol Exp. Ther. 226, 558-564
64. Moore, N.C. and Gershon, S. (1989) Clin. Neuropharmacol. 12, 167-184
65. Zigmond, M.J. et al. (1989) Mol. Chem. Neuropathol. 10, 185-200
66. Grace, A.A. (1992) J. Neural Transm. (Suppl. 36), 91-131
67. Grace, A.A. (1993) J. Neural Transm. 91, 111-134
68. Bowers, M.B. et al. (1989) Biol. Psychiatry 25, 734-738
69. Hollerman, J.R. and Grace, A.A. (1990) Brain Res. 533, 203-212
70. Carlsson, M. and Carlsson, A. (1990) Trends Neurosci. 13, 272-276
71. Weinberger, D.R., Berman, K.F. and Zec, R.F. (1986) Arch. Gen. Psychiatry 43, 111-124